BIOMEDICAL SYSTEMS

BIOMEDICAL SYSTEMS has been active since 1981 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9.1m and a net result of €594,055. Equity is growing by about 5.4% per year across the filed financial years. Its solvency ranks better than 72% of 2,952 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).